Showing results (1361-1370 of 1,437) with videos related to
Sort By:
Pageof 144
Nature Medicine|October 3, 2018
Induction of resistance to chimeric antigen receptor T cell therapy by transduction of a single leukemic B cellMarco Ruella, Jun Xu, David M Barrett, et al.Cancer Cell|April 20, 2005
Activating mutation in the tyrosine kinase JAK2 in polycythemia vera, essential thrombocythemia, and myeloid metaplasia with myelofibrosisRoss L Levine, Martha Wadleigh, Jan Cools, et al.Blood|June 8, 2017
Enasidenib in mutant IDH2 relapsed or refractory acute myeloid leukemiaEytan M Stein, Courtney D DiNardo, Daniel A Pollyea, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 6, 2018
Identification of Clonal Hematopoiesis Mutations in Solid Tumor Patients Undergoing Unpaired Next-Generation Sequencing AssaysCatherine C Coombs, Nancy K Gillis, Xianming Tan, et al.Blood Advances|May 4, 2023
Interaction between myelodysplasia-related gene mutations and ontogeny in acute myeloid leukemiaJoseph G W McCarter, David Nemirovsky, Christopher A Famulare, et al.Nature|March 16, 2023
MEN1 mutations mediate clinical resistance to menin inhibitionFlorian Perner, Eytan M Stein, Daniela V Wenge, et al.Nature Genetics|January 15, 2020
ARID1A determines luminal identity and therapeutic response in estrogen-receptor-positive breast cancerGuotai Xu, Sagar Chhangawala, Emiliano Cocco, et al.Nature Communications|January 13, 2021
Interplay between chromosomal alterations and gene mutations shapes the evolutionary trajectory of clonal hematopoiesisTeng Gao, Ryan Ptashkin, Kelly L Bolton, et al.Blood Advances|October 23, 2020
Diagnostic biomarkers to differentiate sepsis from cytokine release syndrome in critically ill childrenCaroline Diorio, Pamela A Shaw, Edward Pequignot, et al.Blood|December 5, 2018
Molecular remission and response patterns in patients with mutant-IDH2 acute myeloid leukemia treated with enasidenibEytan M Stein, Courtney D DiNardo, Amir T Fathi, et al.Pageof 144